GB0608483D0 - Biomarkers for endometrial proliferation - Google Patents
Biomarkers for endometrial proliferationInfo
- Publication number
- GB0608483D0 GB0608483D0 GBGB0608483.4A GB0608483A GB0608483D0 GB 0608483 D0 GB0608483 D0 GB 0608483D0 GB 0608483 A GB0608483 A GB 0608483A GB 0608483 D0 GB0608483 D0 GB 0608483D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- biomarkers
- endometrial proliferation
- endometrial
- proliferation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000090 biomarker Substances 0.000 title 1
- 230000002357 endometrial effect Effects 0.000 title 1
- 230000035755 proliferation Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57442—Specifically defined cancers of the uterus and endometrial
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Reproductive Health (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pregnancy & Childbirth (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0608483.4A GB0608483D0 (en) | 2006-04-28 | 2006-04-28 | Biomarkers for endometrial proliferation |
| KR1020087026231A KR20090009212A (ko) | 2006-04-28 | 2007-04-26 | 자궁내막 증식에 대한 바이오마커 |
| MX2008013789A MX2008013789A (es) | 2006-04-28 | 2007-04-26 | Biomarcadores para proliferacion endometrial. |
| EP07724624A EP2016417A1 (fr) | 2006-04-28 | 2007-04-26 | Biomarqueurs pour proliferation endometriale |
| JP2009506989A JP2009535023A (ja) | 2006-04-28 | 2007-04-26 | 子宮内膜増殖のバイオマーカー |
| PCT/EP2007/003694 WO2007128429A1 (fr) | 2006-04-28 | 2007-04-26 | Biomarqueurs pour prolifération endométriale |
| BRPI0710912-1A BRPI0710912A2 (pt) | 2006-04-28 | 2007-04-26 | biomarcadores para proliferação endometrial |
| CA002648165A CA2648165A1 (fr) | 2006-04-28 | 2007-04-26 | Biomarqueurs pour proliferation endometriale |
| CNA2007800144769A CN101427139A (zh) | 2006-04-28 | 2007-04-26 | 子宫内膜增殖的生物标记 |
| AU2007247497A AU2007247497A1 (en) | 2006-04-28 | 2007-04-26 | Biomarkers for endometrial proliferation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0608483.4A GB0608483D0 (en) | 2006-04-28 | 2006-04-28 | Biomarkers for endometrial proliferation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0608483D0 true GB0608483D0 (en) | 2006-06-07 |
Family
ID=36590031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0608483.4A Ceased GB0608483D0 (en) | 2006-04-28 | 2006-04-28 | Biomarkers for endometrial proliferation |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2016417A1 (fr) |
| JP (1) | JP2009535023A (fr) |
| KR (1) | KR20090009212A (fr) |
| CN (1) | CN101427139A (fr) |
| AU (1) | AU2007247497A1 (fr) |
| BR (1) | BRPI0710912A2 (fr) |
| CA (1) | CA2648165A1 (fr) |
| GB (1) | GB0608483D0 (fr) |
| MX (1) | MX2008013789A (fr) |
| WO (1) | WO2007128429A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2078728A1 (fr) * | 2008-01-14 | 2009-07-15 | Université de Liège | Nouvelle isoforme du versican et utilisation pour le diagnostic et le traitement |
| EP4341700A1 (fr) * | 2021-05-17 | 2024-03-27 | F. Hoffmann-La Roche AG | Sfrp4 en tant que biomarqueur sanguin pour le diagnostic non invasif de l'adénomyose |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1159601A (en) * | 1999-11-03 | 2001-05-14 | Metris Therapeutics Limited | Agents implicated in endometriosis |
| US20050214836A1 (en) * | 2002-08-30 | 2005-09-29 | Oncotherapy Science, Inc. | Method of diagnosing ovarian endometriosis |
| JP2006526383A (ja) * | 2002-12-23 | 2006-11-24 | インゲニウム ファーマシューティカルズ アクチェンゲゼルシャフト | 杯細胞関連疾患の診断、予防、改善、治療を行なうための方法と薬 |
-
2006
- 2006-04-28 GB GBGB0608483.4A patent/GB0608483D0/en not_active Ceased
-
2007
- 2007-04-26 MX MX2008013789A patent/MX2008013789A/es not_active Application Discontinuation
- 2007-04-26 WO PCT/EP2007/003694 patent/WO2007128429A1/fr not_active Ceased
- 2007-04-26 KR KR1020087026231A patent/KR20090009212A/ko not_active Withdrawn
- 2007-04-26 CN CNA2007800144769A patent/CN101427139A/zh active Pending
- 2007-04-26 CA CA002648165A patent/CA2648165A1/fr not_active Abandoned
- 2007-04-26 JP JP2009506989A patent/JP2009535023A/ja active Pending
- 2007-04-26 BR BRPI0710912-1A patent/BRPI0710912A2/pt not_active IP Right Cessation
- 2007-04-26 EP EP07724624A patent/EP2016417A1/fr not_active Withdrawn
- 2007-04-26 AU AU2007247497A patent/AU2007247497A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007128429A1 (fr) | 2007-11-15 |
| JP2009535023A (ja) | 2009-10-01 |
| KR20090009212A (ko) | 2009-01-22 |
| BRPI0710912A2 (pt) | 2012-02-22 |
| CN101427139A (zh) | 2009-05-06 |
| CA2648165A1 (fr) | 2007-11-15 |
| AU2007247497A1 (en) | 2007-11-15 |
| MX2008013789A (es) | 2008-11-14 |
| EP2016417A1 (fr) | 2009-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0719792D0 (en) | Cancer biomarkers | |
| ZA200907027B (en) | Biomarkers for multiple sclerosis | |
| GB0610828D0 (en) | New use for cannabinoid | |
| EP2087152A4 (fr) | Biomarqueurs endométriaux | |
| GB2436623B (en) | Microtome | |
| EP2095097A4 (fr) | Système xrf à source double | |
| GB0813718D0 (en) | Techniques for interior coordinates | |
| GB0810709D0 (en) | Biomarkers for lupus | |
| GB0818660D0 (en) | Biomarkers | |
| GB0807214D0 (en) | Biomarkers | |
| GB0611701D0 (en) | Analytical apparatus | |
| GB0618127D0 (en) | Biomarker | |
| GB0821912D0 (en) | Biomarkers | |
| GB0818658D0 (en) | Biomarkers | |
| GB0618429D0 (en) | Cancer test | |
| GB0617212D0 (en) | Techniques for endometrial ablation | |
| GB0511302D0 (en) | Biomarkers | |
| GB0612669D0 (en) | Biomarkers for preeclampsia | |
| GB0608483D0 (en) | Biomarkers for endometrial proliferation | |
| GB0617605D0 (en) | Biomarkers | |
| GB0614371D0 (en) | Lighting apparatus | |
| GB0620467D0 (en) | Biomarker | |
| GB0610030D0 (en) | Biomarkers | |
| GB0607710D0 (en) | Biomarkers | |
| GB0621280D0 (en) | Lighting apparatus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |